Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study

Background and purpose Low vitamin D levels, measured by serum 25‐hydroxyvitamin D [25(OH)D], are associated with increased stroke risk. Less is known about whether this association differs by race or D binding protein (DBP) single nucleotide polymorphism (SNP) status. Our objective was to character...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of neurology Vol. 22; no. 8; pp. 1220 - 1227
Main Authors Schneider, A. L. C., Lutsey, P. L., Selvin, E., Mosley, T. H., Sharrett, A. R., Carson, K. A., Post, W. S., Pankow, J. S., Folsom, A. R., Gottesman, R. F., Michos, E. D.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.08.2015
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background and purpose Low vitamin D levels, measured by serum 25‐hydroxyvitamin D [25(OH)D], are associated with increased stroke risk. Less is known about whether this association differs by race or D binding protein (DBP) single nucleotide polymorphism (SNP) status. Our objective was to characterize the associations of and interactions between 25(OH)D levels and DBP SNPs with incident stroke. It was hypothesized that associations of low 25(OH)D with stroke risk would be stronger amongst persons with genotypes associated with higher DBP levels. Methods 25(OH)D was measured by mass spectroscopy in 12 158 participants in the Atherosclerosis Risk in Communities (ARIC) study (baseline 1990–1992, mean age 57 years, 57% female, 23% black) and they were followed through 2011 for adjudicated stroke events. Two DBP SNPs (rs7041, rs4588) were genotyped. Cox models were adjusted for demographic/behavioral/socioeconomic factors. Results During a median of 20 years follow‐up, 804 incident strokes occurred. The lowest quintile of 25(OH)D (<17.2 ng/ml) was associated with higher stroke risk [hazard ratio (HR) 1.34 (1.06–1.71) versus highest quintile]; this association was similar by race (P interaction 0.60). There was weak evidence of increased risk of stroke amongst those with 25(OH)D < 17.2 ng/ml and either rs7041 TG/GG [HR = 1.29 (1.00–1.67)] versus TT genotype [HR = 1.19 (0.94–1.52)] (P interaction 0.28) or rs4588 CA/AA [HR = 1.37 (1.07–1.74)] versus CC genotype [HR = 1.14 (0.91–1.41)] (P interaction 0.11). Conclusions Low 25(OH)D is a risk factor for stroke. Persons with low 25(OH)D who are genetically predisposed to high DBP (rs7041 G, rs4588 A alleles), who therefore have lower predicted bioavailable 25(OH)D, may be at greater risk for stroke, although our results were not conclusive and should be interpreted as hypothesis generating.
Bibliography:National Heart, Lung, and Blood Institute contracts - No. HHSN268201100005C; No. HHSN268201100006C; No. HHSN268201100007C; No. HHSN268201100008C; No. HHSN268201100009C; No. HHSN268201100010C; No. HHSN268201100011C; No. HHSN268201100012C
ark:/67375/WNG-VK418ZCT-P
NIH/NHLBI - No. R01HL103706; No. T32HL007024
ArticleID:ENE12731
NIH Office of Dietary Supplements - No. R01HL103706-S1
NIH/NINDS - No. R01NS072243
Table S1. Participant characteristics by race and 25(OH)D quintile, ARIC visit 2 (1990-1992). Table S2. Adjusted hazard ratios (95% confidence intervals) for incident ischaemic stroke and for incident hemorrhagic stroke by 25(OH)D quintile overall; follow-up 1990-1992 through 2011. Table S3. Adjusted hazard ratios (95% confidence intervals) for incident stroke by vitamin D binding protein polymorphism status; follow-up 1990-1992 through 2011.
NIH/NIDDK - No. R01DK089174
NHLBI CARe (Candidate Gene Resource) - No. N01HC65226
istex:80FFCD05B89332E3BAF8621C1BE6FE4684D46C8D
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1351-5101
1468-1331
1468-1331
DOI:10.1111/ene.12731